Literature DB >> 24228084

Hysteroscopic tubal sterilization: an evidence-based analysis.

K McMartin.   

Abstract

BACKGROUND: Hysteroscopic tubal sterilization is a minimally invasive alternative to laparoscopic tubal ligation for women who want permanent contraception. The procedures involves non-surgical placement of permanent microinserts into both fallopian tubes. Patients must use alternative contraception for at least 3 months postprocedure until tubal occlusion is confirmed. Compared to tubal ligation, potential advantages of the hysteroscopic procedure are that it can be performed in 10 minutes in an office setting without the use of general or even local anesthesia.
OBJECTIVE: The objective of this analysis was to determine the effectiveness and safety of hysteroscopic tubal sterilization compared with tubal ligation for permanent female sterilization. DATA SOURCES: A standard systematic literature search was conducted for studies published from January 1, 2008, until December 11, 2012. REVIEW
METHODS: Observational studies, randomized controlled trials (RCTs), systematic reviews and meta-analyses with 1 month or more of follow-up were examined. Outcomes included failure/pregnancy rates, adverse events, and patient satisfaction.
RESULTS: No RCTs were identified. Two systematic reviews covered 22 observational studies of hysteroscopic sterilization. Only 1 (N = 93) of these 22 studies compared hysteroscopic sterilization to laparoscopic tubal ligation. Two other noncomparative case series not included in the systematic reviews were also identified. In the absence of comparative studies, data on tubal ligation were derived for this analysis from the CREST study, a large, multicentre, prospective, noncomparative observational study in the United States (GRADE low). Overall, hysteroscopic sterilization is associated with lower pregnancy rates and lower complication rates compared to tubal ligation. No deaths have been reported for hysteroscopic sterilization. LIMITATIONS: A lack of long-term follow-up for hysteroscopic sterilization and a paucity of studies that directly compare the two procedures limit this assessment. In addition, optimal placement of the microinsert at the time of hysteroscopy varied among studies.
CONCLUSIONS: Hysteroscopic sterilization is associated with: lower pregnancy rates compared to tubal ligation (GRADE very low); lower complication rates compared to tubal ligation (GRADE very low); no significant improvement in patient satisfaction compared to tubal ligation (GRADE very low). PLAIN LANGUAGE
SUMMARY: Hysteroscopic tubal sterilization is a minimally invasive alternative to conventional tubal ligation for women who want a permanent method of contraception. Both approaches involve closing off the fallopian tubes, preventing the egg from moving down the tube and the sperm from reaching the egg. Tubal ligation is a surgical procedure to tie or seal the fallopian tubes, and it usually requires general anesthesia. In contrast, hysteroscopic tubal sterilization can be performed in 10 minutes in an office setting without general or even local anesthesia. A tiny device called a microinsert is inserted into each fallopian tube through the vagina, cervix, and uterus without surgery. An instrument called a hysteroscope allows the doctor to see inside the body for the procedure. Once the microinserts are in place, scar tissue forms around them and blocks the fallopian tubes. Health Quality Ontario conducted a review of the effectiveness and safety of hysteroscopic tubal sterilization compared to tubal ligation. This review indicates that hysteroscopic tubal sterilization is associated with: lower pregnancy rates compared to tubal ligation; lower complication rates compared to tubal ligation; no significant improvement in patient satisfaction compared to tubal ligation. However, we found a number of limitations to the studies available on hysteroscopic tubal sterilization. Among other concerns, most studies did not include long-term follow-up and only 1 study directly compared hysteroscopic tubal sterilization to tubal ligation.

Entities:  

Mesh:

Year:  2013        PMID: 24228084      PMCID: PMC3819111     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN: 1915-7398


  37 in total

1.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology.

Authors:  Gordon H Guyatt; Andrew D Oxman; Holger J Schünemann; Peter Tugwell; Andre Knottnerus
Journal:  J Clin Epidemiol       Date:  2010-12-24       Impact factor: 6.437

2.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.

Authors:  H B Peterson; Z Xia; J M Hughes; L S Wilcox; L R Tylor; J Trussell
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

3.  Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre.

Authors:  B Povedano; J E Arjona; E Velasco; J A Monserrat; J Lorente; C Castelo-Branco
Journal:  BJOG       Date:  2012-02-23       Impact factor: 6.531

Review 4.  Pregnancies after hysteroscopic sterilization: a systematic review.

Authors:  Tara P Cleary; Naomi K Tepper; Carrie Cwiak; Maura K Whiteman; Denise J Jamieson; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

5.  Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system.

Authors:  John F Kerin; David N Munday; Martin G Ritossa; Andrew Pesce; David Rosen
Journal:  J Am Assoc Gynecol Laparosc       Date:  2004-08

6.  Initial Asian experience in hysteroscopic sterilisation using the Essure permanent birth control device.

Authors:  Bernard Chern; Anthony Siow
Journal:  BJOG       Date:  2005-09       Impact factor: 6.531

7.  Hysteroscopic sterilization in a large group practice: experience and effectiveness.

Authors:  Ulrike K Savage; Steven J Masters; Marcela C Smid; Yun-Yi Hung; Gavin F Jacobson
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

8.  Analysis of pain and satisfaction with office-based hysteroscopic sterilization.

Authors:  Mark Levie; Gil Weiss; Bente Kaiser; Jennifer Daif; Scott G Chudnoff
Journal:  Fertil Steril       Date:  2009-08-14       Impact factor: 7.329

9.  Unintended pregnancies after Essure sterilization in the Netherlands.

Authors:  Sebastiaan Veersema; Michel P H Vleugels; Lobke M Moolenaar; Catharina A H Janssen; Hans A M Brölmann
Journal:  Fertil Steril       Date:  2008-11-21       Impact factor: 7.329

10.  Efficacy, safety, and patient acceptability of the Essure™ procedure.

Authors:  Collette R Lessard; Matthew R Hopkins
Journal:  Patient Prefer Adherence       Date:  2011-04-28       Impact factor: 2.711

View more
  3 in total

1.  The effectiveness of planned discharge education on health knowledge and beliefs in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Serap Tuna; Sezgi Çınar Pakyüz
Journal:  Ir J Med Sci       Date:  2021-03-17       Impact factor: 1.568

2.  Implementation, spread and impact of the Patient Oriented Discharge Summary (PODS) across Ontario hospitals: a mixed methods evaluation.

Authors:  Shoshana Hahn-Goldberg; Tai Huynh; Audrey Chaput; Murray Krahn; Valeria Rac; George Tomlinson; John Matelski; Howard Abrams; Chaim Bell; Craig Madho; Christine Ferguson; Ann Turcotte; Connie Free; Sheila Hogan; Bonnie Nicholas; Betty Oldershaw; Karen Okrainec
Journal:  BMC Health Serv Res       Date:  2021-04-17       Impact factor: 2.655

3.  Temporal trend in the use of hysteroscopic vs laparoscopic sterilization and the characteristics of commercially insured and Medicaid-insured females in the US who have had the procedures.

Authors:  Patricia I Carney; Jay Lin; Fang Xia; Amy Law
Journal:  Int J Womens Health       Date:  2016-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.